|
US3809767A
(en)
|
1969-05-12 |
1974-05-07 |
Griffith Laboratories |
Methods of making vegetable protein concentrates
|
|
AU1589492A
(en)
|
1991-03-01 |
1992-10-06 |
Warner-Lambert Company |
Starch-based controlled release compositions
|
|
US20120164306A1
(en)
|
1993-08-03 |
2012-06-28 |
Girsh Leonard S |
Process for preparing hypoallergenic and reduced fat foods
|
|
JP3445593B2
(ja)
|
1994-09-10 |
2003-09-08 |
株式会社林原生物化学研究所 |
ペプチドとその用途
|
|
AU2065801A
(en)
|
1999-12-06 |
2001-06-12 |
Panacea Pharmaceuticals, Llc |
Passive desensitization
|
|
AU1951001A
(en)
|
2000-04-06 |
2001-09-17 |
Panacea Pharm Llc |
Microbial delivery system
|
|
WO2004047793A1
(en)
|
2002-11-26 |
2004-06-10 |
Alk-Abelló A/S |
Pharmaceutical allergen product
|
|
EP1599185A1
(en)
|
2003-02-28 |
2005-11-30 |
Alk-Abello A/S |
Dosage form having a saccharide matrix
|
|
EP1734975B1
(en)
|
2004-03-19 |
2015-06-10 |
Herbs Spring, LLC |
Herbal therapy for the treatment of food allergy
|
|
WO2005100995A2
(en)
|
2004-04-06 |
2005-10-27 |
Mount Sinai School Of Medicine |
Methods of determining allergen response using microarray imminoassay techinques
|
|
BRPI0520821A2
(pt)
|
2005-12-28 |
2009-06-30 |
Teva Pharma |
formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada
|
|
US8309088B2
(en)
|
2007-08-10 |
2012-11-13 |
Regeneron Pharmaceuticals, Inc. |
Method of treating osteoarthritis with an antibody to NGF
|
|
HRP20200284T1
(hr)
|
2008-10-02 |
2020-07-10 |
Salix Pharmaceuticals, Ltd. |
Postupci liječenja hepatičke encefalopatije
|
|
BRPI0921507A2
(pt)
|
2008-11-19 |
2016-01-19 |
Avantor Performance Mat Inc |
composição, método de preparação de um excipiente, comprimido farmacêutico e método de preparação do mesmo
|
|
US8399519B2
(en)
|
2008-12-19 |
2013-03-19 |
Merz Pharma Gmbh & Co. Kgaa |
1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
|
|
US8329208B2
(en)
|
2009-07-28 |
2012-12-11 |
Methylation Sciences International Srl |
Pharmacokinetics of S-adenosylmethionine formulations
|
|
EP2364690A1
(en)
|
2010-02-12 |
2011-09-14 |
Centro De Ingenieria Genetica Y Biotecnologia |
Orally administrable pharmaceutical pellet of epidermal growth factor
|
|
JP5800527B2
(ja)
|
2010-03-30 |
2015-10-28 |
日東電工株式会社 |
安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
|
|
AR081776A1
(es)
|
2010-06-30 |
2012-10-17 |
Novartis Ag |
Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
|
|
GB201104537D0
(en)
|
2011-03-17 |
2011-05-04 |
Cambridge Entpr Ltd |
Treatment for peanut allergy
|
|
US20140207105A1
(en)
|
2011-08-31 |
2014-07-24 |
Perosphere, Inc. |
Methods for Effectively and Rapidly Desensitizing Allergic Patients
|
|
WO2013087119A1
(en)
|
2011-12-16 |
2013-06-20 |
Hal Allergy Holding B.V. |
Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
|
|
CN104080465A
(zh)
|
2012-01-13 |
2014-10-01 |
科.汉森有限公司 |
用于预防或治疗上呼吸道感染的鼠李糖乳杆菌和动物双歧杆菌乳亚种
|
|
WO2014159609A1
(en)
|
2013-03-14 |
2014-10-02 |
Allergen Research Corporation |
Peanut formulations and uses thereof
|
|
CN109125283A
(zh)
|
2013-03-14 |
2019-01-04 |
艾慕恩治疗公司 |
用于口服脱敏的花生制剂的制备
|
|
KR102233251B1
(ko)
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
신규 나노입자 조성물
|
|
US9456628B2
(en)
|
2013-06-13 |
2016-10-04 |
D&E Gillespie Enterpries LLC |
Methods and products to provide oral nutritional care to subjects with dementia
|
|
US20150343075A1
(en)
|
2014-06-02 |
2015-12-03 |
Aimmune Therapeutics |
Placebo formulations and uses thereof
|
|
EP3185900A4
(en)
|
2014-08-25 |
2018-05-02 |
Aimmune Therapeutics, Inc. |
Egg protein formulations and methods of manufacture thereof
|
|
GEAP201814459A
(en)
|
2014-09-04 |
2018-09-10 |
Helsinn Healthcare Sa |
Medical treatments based on anamorelin
|
|
UA122670C2
(uk)
|
2014-09-08 |
2020-12-28 |
Сефалон, Інк. |
Спосіб лікування еозинофільної астми у пацієнта
|
|
WO2016138030A2
(en)
|
2015-02-23 |
2016-09-01 |
Antera Therapeutics Inc. |
Compositions and methods for tolerizing the immune system to allergens
|
|
SG11201708721XA
(en)
*
|
2015-04-28 |
2017-11-29 |
Shionogi & Co |
Substituted polycyclic pyridone derivative and prodrug thereof
|
|
JP2020514306A
(ja)
|
2017-01-13 |
2020-05-21 |
アイミューン セラピューティクス，インコーポレイテッド |
経口免疫療法用のナッツ粉および製剤の製造方法
|
|
FR3062797B1
(fr)
|
2017-02-10 |
2025-03-07 |
Centre Hospitalier Et Univ De Clermont Ferrand |
Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide
|
|
US11369676B2
(en)
|
2017-11-02 |
2022-06-28 |
Société des Produits Nestlé S.A. |
Methods of oral immunotherapy
|
|
USD866321S1
(en)
|
2018-07-27 |
2019-11-12 |
Aimmune Therapeutics, Inc. |
Box of boxes for dispensing medicine
|
|
USD866322S1
(en)
|
2018-07-27 |
2019-11-12 |
Aimmune Therapeutics, Inc. |
Medicine folio
|
|
EP3829632A4
(en)
|
2018-07-27 |
2022-05-04 |
Société des Produits Nestlé S.A. |
SYSTEMS AND METHODS FOR DELIVERING UNIT DOSES OF ORAL IMMUNOTHERAPY
|
|
USD866320S1
(en)
|
2018-07-27 |
2019-11-12 |
Aimmune Therapeutics, Inc. |
Box of boxes for dispensing medicine
|
|
US12433945B2
(en)
|
2018-08-16 |
2025-10-07 |
Société des Produits Nestlé S.A. |
Peanut oral immunotherapy with maintenance dose
|
|
AU2019401576A1
(en)
|
2018-12-17 |
2021-06-24 |
Société des Produits Nestlé S.A. |
Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
|
|
EP3942299A4
(en)
|
2019-03-22 |
2023-06-28 |
Société des Produits Nestlé S.A. |
Systemic allergic response risk assessment in peanut oral immunotherapy
|
|
CA3137295A1
(en)
|
2019-05-10 |
2020-11-19 |
Aimmune Therapeutics, Inc. |
Methods for improving the quality of life of a patient with a peanut allergy
|